Equity Capital Markets

Company · CIK 1971532

Telomir Pharmaceuticals, Inc.

CIK1971532 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inFL
Business addressFL
ListedTELO (Nasdaq)
First annual or quarterly report2024-03-29

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-284990
ShelfEffective
 2025-02-142025-02-282
333-275534
IPOFinal prospectus
 2023-11-142024-02-127

Filings

10
FiledFilingRegistrationAccession
2025-02-28EFFECTDeclared effective 333-2849909999999995-25-000561
2025-02-14S-3Shelf registered 333-2849900001493152-25-006943
2024-02-12424B4Final prospectus 333-2755340001493152-24-005876
2024-02-12424B1Final prospectus 333-2755340001493152-24-005873
2024-02-08EFFECTDeclared effective 333-2755349999999995-24-000352
2024-01-03S-1/AAmendment 333-2755340001493152-24-000217
2023-12-19S-1/AAmendment 333-2755340001493152-23-045454
2023-12-14S-1/AAmendment 333-2755340001493152-23-044902
2023-11-14S-1Registration filed 333-2755340001493152-23-040696
2023-08-14DRSDraft made public 377-068210001493152-23-028488

All filings of this company · CSV